肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

转录组分析揭示,即使具有相似的遗传背景,原发性浆细胞白血病与多发性骨髓瘤之间仍存在显著差异

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

原文发布日期:2019-11-20

DOI: 10.1038/s41408-019-0253-1

类型: Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

转录组分析揭示,即使具有相似的遗传背景,原发性浆细胞白血病与多发性骨髓瘤之间仍存在显著差异

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

原文发布日期:2019-11-20

DOI: 10.1038/s41408-019-0253-1

类型: Article

开放获取: 是

 

英文摘要:

Primary plasma cell leukemia (pPCL) is a highly aggressive plasma cell dyscrasia characterised by short remissions and very poor survival. Although the 17p deletion is associated with poor outcome and extramedullary disease in MM, its presence does not confer the degree of aggressiveness observed in pPCL. The comprehensive exploration of isoform expression and RNA splicing events may provide novel information about biological differences between the two diseases. Transcriptomic studies were carried out in nine newly diagnosed pPCL and ten MM samples, all of which harbored the 17p deletion. Unsupervised cluster analysis clearly distinguished pPCL from MM samples. In total 3584 genes and 20033 isoforms were found to be deregulated between pPCL and MM. There were 2727 significantly deregulated isoforms of non-differentially expressed genes. Strangely enough, significant differences were observed in the expression of spliceosomal machinery components between pPCL and MM, in respect of the gene, isoform and the alternative splicing events expression. In summary, transcriptome analysis revealed significant differences in the relative abundance of isoforms between pPCL and MM, even when they both had the 17p deletion. The mRNA processing pathway including RNA splicing machinery emerged as one of the most remarkable mechanisms underlying the biological differences between the two entities.
 

摘要翻译: 

原发性浆细胞白血病(pPCL)是一种高度侵袭性的浆细胞恶液质,其特征是缓解期短且生存率极低。虽然17号染色体短臂缺失(17p缺失)与多发性骨髓瘤(MM)的不良预后和髓外病变相关,但其存在并不能解释pPCL中观察到的侵袭程度。对亚型表达和RNA剪接事件的全面探索可能为两种疾病之间的生物学差异提供新信息。研究人员对9例新诊断的pPCL和10例MM样本进行了转录组学研究,所有样本均携带17p缺失。无监督聚类分析清晰区分了pPCL与MM样本。总共发现3584个基因和20033种亚型在pPCL与MM之间存在失调现象。其中存在2727个非差异表达基因的显著失调亚型。值得注意的是,在剪接体机制组件的基因、亚型及可变剪接事件表达方面,pPCL与MM之间呈现显著差异。总之,转录组分析揭示即使同样携带17p缺失,pPCL与MM在亚型相对丰度方面仍存在显著差异。包含RNA剪接机制在内的mRNA加工通路,成为两者生物学差异中最显著的潜在机制之一。

 

原文链接:

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……